Skip to main content
Elias Reichel, MD, Ophthalmology, Boston, MA

Elias Reichel MD

Retinal Disease, Uveitis


Professor, Ophthalmology, Tufts Medical Center

Join to View Full Profile
  • 260 Tremont StreetBwd 10Boston, MA 02116

  • Phone+1 617-636-1648

  • Fax+1 617-636-4866

Dr. Reichel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical School
    Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 1989 - 1992
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1986 - 1987
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1986

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1992 - 2025
  • FL State Medical License
    FL State Medical License 2012 - 2018
  • ME State Medical License
    ME State Medical License Active through 2000
  • RI State Medical License
    RI State Medical License 1996 - 1999
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Market Cap of EyePoint Pharmaceuticals Inc. [EYPT] Reaches 65.23M – Now What?
    Market Cap of EyePoint Pharmaceuticals Inc. [EYPT] Reaches 65.23M – Now What?November 27th, 2020
  • EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD on December 4
    EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD on December 4November 19th, 2020
  • Citation: Versek C, Banijamali SMA, Bex PJ, Lashkari J, Kamarthi SC, Sridhar S (2020) Portable Objective Diagnostics Using Visual Evoked Potentials for Age-Related Macular Degeneration. J Clin Exp Ophthalmol. 11:863
    Citation: Versek C, Banijamali SMA, Bex PJ, Lashkari J, Kamarthi SC, Sridhar S (2020) Portable Objective Diagnostics Using Visual Evoked Potentials for Age-Related Macular Degeneration. J Clin Exp Ophthalmol. 11:863November 2nd, 2020
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: